Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.


HHS - 1844 - Sleep Disorders Research Advisory Board - Statutory (Congress Created)
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameSleep Disorders Research Advisory BoardAgency NameDepartment of Health and Human Services
Fiscal Year2020Committee Number1844
Original Establishment Date11/10/1993Committee StatusChartered
Actual Termination Date Committee URLhttps://www.nhlbi.nih.gov/node/80106
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*22
Current Charter Date6/30/2019Designated Fed Officer Position Title*Director, National Center on Sleep Disorders Research
Date Of Renewal Charter6/30/2021Designated Federal Officer Prefix
Projected Termination Date Designated Federal Officer First Name*Michael
Exempt From Renewal*NoDesignated Federal Officer Middle NameJ
Specific Termination AuthorityDesignated Federal Officer Last Name*Twery
Establishment Authority*Statutory (Congress Created)Designated Federal Officer SuffixPHD
Specific Establishment Authority*42 USC 285b-7 et seq.Designated Federal Officer Phone*(301) 435-0202
Effective Date Of Authority*6/10/1993Designated Federal Officer Fax*(301) 480-3557
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*twerym@mail.nih.gov
Committee Type*Continuing
Presidential*No
Committee Function*Scientific Technical Program Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The Sleep Disorders Research Advisory Board (SDRAB) is composed of highly qualified scientific and public individuals with expertise and experience related to the National Center on Sleep Disorders Research (NCSDR) in the National Heart, Lung, and Blood Institute. The Board provides a breadth and balance of specialized knowledge necessary to assess the long-range goals, program concepts, research opportunities, and appraise the direction of current and future sleep and circadian research. At each meeting, scientific and education program updates from NCSDR, NIH Institutes and Centers, and other federal agencies provide a framework for the identification of scientific needs and opportunities. The Board also advises NCSDR on the development of programs to promote sleep as part of a healthy lifestyle, increase public awareness of sleep disorders, and disseminate new findings potentially relevant to clinical practice and future research. Recent priorities include health and disease in national health surveillance surveys; and a new research initiative to elucidate mechanisms linking circadian biology to heart, lung, and blood diseases.
How is membership balanced?*The Board consists of 12 authorized members who are authorities knowledgeable in the disciplines pertinent to the activities of the National Center on Sleep Disorders Research. Eight of the members represent health and scientific disciplines with respect to sleep disorders and four represent the interests of individuals with or undergoing treatment for sleep disorders.
How frequent & relevant are cmte mtgs?*The Sleep Disorders Research Advisory Board (SDRAB) meets three times a year. For FY2020 the committee only met twice due to a lack of availability of members for a quorum. The committee met on February 6, 2020 and June 11, 2020. A major focus in fiscal year 2020 has been receiving input from researchers, public stakeholders, and NIH program representatives on needs and opportunities for inclusion in a revision of the NIH Sleep Research Plan. A list of opportunities identified by the Board was developed to include examples of specific research activities. The Board has also been presented several analyses on the status of sleep and circadian grant applications submitted to the NIH, how the findings generated by NIH sleep and circadian research are contributing to other areas of biomedical research, and the numbers of NIH funded sleep and circadian researchers. New avenues of research coordination within NIH and with other Federal Agencies are discussed at each meeting.
Why advice can't be obtained elsewhere?*The Board was established by legislation (42 U.S.C. 285b-7) to provide advice to the Director, National Institutes of Health; the Director, National Heart Lung and Blood Institute; and the Director of the National Center for Sleep Disorders Research on matters related to the planning, execution, conduct, support and evaluation of research in basic sleep and sleep disorders. The Board assesses the needs of sleep disorder patients, public stakeholders, and researchers aiding in programmatic development relevant to the mission of nearly every NIH Institute, Center, and Office. The Board serves as a central venue where public and programmatic opportunities can be efficiently coordinated. The Board is composed of both professional and lay members who are experts in the fields of sleep research and disorders. Their recommendations cannot be obtained from other sources because the complex multi-disciplinary nature of the research requiring a specialized balance and breadth of expertise not available on the NIH staff or from other established sources.
Why close or partially close meetings?NA
Recommendation RemarksReports: The Board did not produce any public reports for this fiscal year.

DFO and Committee Decision Maker positions are held by the same individual based on assigned duties within the Institute.

Member(s): During FY20, Dr. Gabriel Haddad was appointed as chair.

Meeting(s): Due to member availability and unable to meet a quorum, the committee met twice this FY, instead of the usual three times a year.

Ex Officio Membership: Four new Ex Officio members (Gibbons, Gordon, He, Mackiewicz) were appointed
to SDRAB, as indicated in the Charter. Two current Ex Officio members (Collins and Twery) remain on the roster as well, for a total of six Ex Officios.

Ex Officio Member Costs: Daily salary costs have been estimated for Ex Officio members of this committee. The dollar figure represents a portion of their annual salary. No funds have been transferred between the committee and the agency. Although six Ex Officios are identified in the member section, only two attended both meetings this year.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*NoAction Reorganize Priorities*Yes
Outcome Trust In GovernmentNoAction Reallocate ResourcesNo
Outcome Major Policy ChangesNoAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryYesAction OtherNo
Outcome Increased Customer SatisfactionNoAction CommentNA
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNANumber Of Grants Recommended0
Cost Savings*NoneDollar Value Of Grants Recommended$0.00
Cost Savings CommentNIH supported basic and clinical research accomplishments often take many years to unfold into new diagnostic tests and new ways to treat and prevent diseases.Grants Review CommentNA
Number Of Recommendations*54Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentIn FY2020, SDRAB made four recommendations
1) Identified nine critical challenges, five goal areas, and seventy examples of specific research opportunities distributed across the five goals for consideration in the revision of the Sleep Disorders Research Plan. Biomarker development was recommended as an over-arching priority serving all research directions.
2) The Board recommended that their pentultimate draft of a revised Sleep Disorders Research Plan be sent forward for consideration by NIH programs.
3) The Board recommended the development of bibliometric approaches to better understand how advances in sleep and circadian sciences are utilized in other scientific fields and to identify programmatic opportunities for research coordination.
4) The Board recommended NCSDR explore transNIH opportunities for research coordination related to chronobiology.
Access Agency WebsiteYes
% of Recs Fully Implemented*0.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentDue to the complexity of the recommendations made by this committee, staff is unable to determine which recommendations have been fully or partially implemented solely in response to this committee's activities.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*0.00%Access PublicationsNo
% of Recs Partially Implemented CommentDue to the complexity of the recommendations made by this committee, staff is unable to determine which recommendations have been fully or partially implemented solely in response to this committee's activities.Access OtherNo
Agency Feedback*YesAccess CommentNA
Agency Feedback Comment*At each Board meeting, the Director of the National Center on Sleep Disorders provides a report pertaining to recommendations produced by the Board at the last meeting or in process subsequent to an earlier meeting.Narrative Description*The goal of NIH research is to acquire new knowledge to help prevent, detect, diagnose, and treat disease and disability, from the rarest genetic disorder to the common cold. The NIH mission is to uncover new knowledge that will lead to better health for everyone. NIH works toward that mission by the establishment of a National Center on Sleep Disorders Research whose purpose is to support research training, training, health information dissemination, and other activities with respect to sleep disorders, and coordinate these activities with similar ones of other NIH components, Federal agencies and for-profit and nonprofit entities.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$3,800.00Est Payments to Non-Fed Members Next FY*$3,800.00
Payments to Federal Members*$3,930.00Est. Payments to Fed Members Next FY*$3,930.00
Payments to Federal Staff*$37,571.00Estimated Payments to Federal Staff*$43,125.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$6,665.00Est Travel Reimb Non-Fed Members nextFY*$6,702.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$2,270.00Est Travel Reimb to Consultants Next FY*$2,281.00
Other Costs$0.00Est. Other Costs Next FY*$0.00
Total Costs$54,236.00Est. Total Next FY*$59,838.00
Federal Staff Support (FTE)*0.20Est. Fed Staff Support Next FY*0.30
Cost RemarksThe February Meeting was held in person, however the June meeting was held via Videoconference due to the Covid-19 pandemic. This reduced the projected meeting cost for FY2020 that was projected in FY2019.Est Cost RemarksProjected costs for FY21 are for in-person meetings and are subject to change.
Hide Section - Interest Areas

Interest Areas

Category
Area
Health
Health Care
Public Health
Medicine
Health and Health Research
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-036649Sleep Disorders Research Advisory Board2019
 COM-034863Sleep Disorders Research Advisory Board2018
 COM-001910Sleep Disorders Research Advisory Board2017
 COM-002309Sleep Disorders Research Advisory Board2016
 COM-004094Sleep Disorders Research Advisory Board2015
 COM-004508Sleep Disorders Research Advisory Board2014
 COM-006220Sleep Disorders Research Advisory Board2013
 COM-006936Sleep Disorders Research Advisory Board2012
 COM-008366Sleep Disorders Research Advisory Board2011
 COM-008734Sleep Disorders Research Advisory Board2010
 COM-010038Sleep Disorders Research Advisory Board2009
 COM-010727Sleep Disorders Research Advisory Board2008
 COM-012173Sleep Disorders Research Advisory Board2007
 COM-012660Sleep Disorders Research Advisory Board2006
 COM-013765Sleep Disorders Research Advisory Board2005
 COM-014540Sleep Disorders Research Advisory Board2004
 COM-015705Sleep Disorders Research Advisory Board2003
 COM-016771Sleep Disorders Research Advisory Board2002
 COM-017932Sleep Disorders Research Advisory Board2001
 COM-018443Sleep Disorders Research Advisory Board2000
 COM-019850Sleep Disorders Research Advisory Board1999
 COM-020598Sleep Disorders Research Advisory Board1998
 COM-021440Sleep Disorders Research Advisory Board1997